NCT06117722View on ClinicalTrials.gov

TorasEmide Induced Effect on QoL and Clinical parameterS in paTients With chronIc heArt Failure Receiving Eplerenone.

RecruitingOBSERVATIONAL
Enrollment

210

Participants

Timeline

Start Date

March 6, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

December 31, 2025

Conditions
Chronic Heart Failure
Interventions
OTHER

Eplerenone torasemide in chronic heart failure

Heart Failure patients treated with eplerenone and torasemide

Trial Locations (1)

12462

RECRUITING

ATTIKON University Hospital, Athens

Sponsors
All Listed Sponsors
lead

Elpen Pharmaceutical Co. Inc.

INDUSTRY